Literature DB >> 33084420

Potential role of imaging markers in predicting future disease expression of arrhythmogenic cardiomyopathy.

Emanuele Monda1, Giulia Frisso2,3, Marta Rubino1, Martina Caiazza1, Augusto Esposito1, Annapaola Cirillo1, Adelaide Fusco1, Giuseppe Palmiero1, Cristina Mazzaccara2,3, Roberta Pacileo1, Federica Verrillo1, Francesco Di Fraia1, Felice Gragnano4, Arturo Cesaro4, Francesco Salvatore2,3, Maria Giovanna Russo1, Paolo Calabrò4, Giuseppe Pacileo1, Santo Dellegrottaglie5,6, Giuseppe Limongelli1,7.   

Abstract

Aim: To evaluate the predictive accuracy of trabecular hypertrophy/derangement and late gadolinium enhancement in predicting diagnosis of arrhythmogenic cardiomyopathy (AC). Materials & methods: Fifty-nine suspected AC patients were evaluated. To evaluate the ability of these markers to detect patients fulfilling definite diagnosis at 4-year follow-up, sensitivity (Se), specificity (Sp), positive and negative predictive value (PPV and NPV) and predictive accuracy (PA) were calculated.
Results: Presence of trabecular hypertrophy/derangement showed high NPV, while late gadolinium enhancement at cardiac MRI high Sp, NPV and PA. Their combination with symptoms and/or revised Task Force Criteria showed a high Sp, NPV and PA for definitive diagnosis during follow-up.
Conclusion: In suspected AC patients, the absence of these markers allows to identify those with lower risk of disease progression.

Entities:  

Keywords:  arrhythmogenic cardiomyopathy; diagnosis; late gadolinium enhancement; red flags; trabecular hypertrophy

Year:  2020        PMID: 33084420     DOI: 10.2217/fca-2020-0107

Source DB:  PubMed          Journal:  Future Cardiol        ISSN: 1479-6678


  3 in total

1.  Loss-of-Function FLNC Variants Are Associated With Arrhythmogenic Cardiomyopathy Phenotypes When Identified Through Exome Sequencing of a General Clinical Population.

Authors:  Eric D Carruth; Maria Qureshi; Amro Alsaid; Melissa A Kelly; Hugh Calkins; Brittney Murray; Crystal Tichnell; Amy C Sturm; Aris Baras; H Lester Kirchner; Brandon K Fornwalt; Cynthia A James; Christopher M Haggerty
Journal:  Circ Genom Precis Med       Date:  2022-06-14

Review 2.  Multimodality Imaging in Cardiomyopathies with Hypertrophic Phenotypes.

Authors:  Emanuele Monda; Giuseppe Palmiero; Michele Lioncino; Marta Rubino; Annapaola Cirillo; Adelaide Fusco; Martina Caiazza; Federica Verrillo; Gaetano Diana; Alfredo Mauriello; Michele Iavarone; Maria Angela Losi; Maria Luisa De Rimini; Santo Dellegrottaglie; Antonello D'Andrea; Eduardo Bossone; Giuseppe Pacileo; Giuseppe Limongelli
Journal:  J Clin Med       Date:  2022-02-07       Impact factor: 4.964

3.  Arrhythmogenic Right Ventricular Cardiomyopathy: Improvement of Diagnosis and Risk Stratification by Implementation of Echocardiographic Normative Values in Children.

Authors:  Stefan Kurath-Koller; Martin Koestenberger
Journal:  Front Pediatr       Date:  2022-03-22       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.